Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125775001 | 12577500 | 1 | I | 2015 | 20160504 | 20160720 | 20160720 | EXP | US-ASTRAZENECA-2016SE49613 | ASTRAZENECA | 50.00 | YR | M | Y | 70.80000 | KG | 20160721 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125775001 | 12577500 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, TWO PUFFS TWICE A DAY | 21929 | ||||||||||
| 125775001 | 12577500 | 2 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, TWO PUFFS TWICE A DAY | 21929 | ||||||||||
| 125775001 | 12577500 | 3 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, TWO PUFFS TWICE A DAY | 21929 | ||||||||||
| 125775001 | 12577500 | 4 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | |||||||||
| 125775001 | 12577500 | 5 | C | ALBUTEROL VIA NEBULIZER | 2 | Respiratory (inhalation) | 0 | ||||||||||||
| 125775001 | 12577500 | 6 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | DAILY | 0 | ||||||||||
| 125775001 | 12577500 | 7 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 125775001 | 12577500 | 8 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 125775001 | 12577500 | 9 | C | RETINAL | 2 | 0 | |||||||||||||
| 125775001 | 12577500 | 10 | C | RETINAL | 2 | 0 | |||||||||||||
| 125775001 | 12577500 | 11 | C | MAGNESIUM OTC | 2 | 0 | |||||||||||||
| 125775001 | 12577500 | 12 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125775001 | 12577500 | 1 | Chronic obstructive pulmonary disease |
| 125775001 | 12577500 | 2 | Emphysema |
| 125775001 | 12577500 | 3 | Bronchitis |
| 125775001 | 12577500 | 4 | Gastric disorder |
| 125775001 | 12577500 | 7 | Lung disorder |
| 125775001 | 12577500 | 8 | Lung disorder |
| 125775001 | 12577500 | 9 | Joint stiffness |
| 125775001 | 12577500 | 10 | Muscle spasms |
| 125775001 | 12577500 | 11 | Muscle spasms |
| 125775001 | 12577500 | 12 | Gastric disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125775001 | 12577500 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125775001 | 12577500 | Abdominal discomfort | |
| 125775001 | 12577500 | Abdominal pain upper | |
| 125775001 | 12577500 | Asthenia | |
| 125775001 | 12577500 | Back pain | |
| 125775001 | 12577500 | Cough | |
| 125775001 | 12577500 | Drug dose omission | |
| 125775001 | 12577500 | Dyspnoea | |
| 125775001 | 12577500 | Headache | |
| 125775001 | 12577500 | Intentional product misuse | |
| 125775001 | 12577500 | Joint stiffness | |
| 125775001 | 12577500 | Pain | |
| 125775001 | 12577500 | Rib fracture | |
| 125775001 | 12577500 | Viral test positive | |
| 125775001 | 12577500 | Vomiting | |
| 125775001 | 12577500 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125775001 | 12577500 | 1 | 2014 | 0 | ||
| 125775001 | 12577500 | 2 | 2014 | 0 | ||
| 125775001 | 12577500 | 3 | 2014 | 0 | ||
| 125775001 | 12577500 | 9 | 201601 | 0 | ||
| 125775001 | 12577500 | 10 | 201601 | 0 | ||
| 125775001 | 12577500 | 12 | 20160531 | 0 |